Ionis Pharmaceuticals (Nasdaq: IONS) announced it will present new data on treatments for severe hypertriglyceridemia (sHTG) at the European Society ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE